With its Novel Foods deadline just one week away, UK industry pioneers BRITISH CANNABIS are providing a much-needed lifeline to CBD brands.
In just one week’s time, BRITISH CANNABIS will submit multiple Novel Food dossiers to the Food Standards Agency (FSA) to cover both its branded portfolio and its white label client’s CBD food products.
The company is part of both the Association for The Cannabinoid Industry’s (ACI) Safety Consortium study and a newly-announced Primary Authority Partnership with Trading Standards. Both of which should be confidence boosters for consumers and resellers.
CBD businesses in the UK are now being offered a last-minute opportunity to name their products within the BRITISH CANNABIS dossier submission with no upfront costs or commitments.
Several of the CBD industry’s most successful and fastest-growing CBD brands have already switched their manufacturer to being powered by BRITISH CANNABIS™ in the wake of Novel Foods and post-Brexit supply chain issues.
With its Novel Foods deadline just seven days away, the industry-original and early pioneer, is providing a much-needed lifeline to CBD brands to piggyback a products’ name onto its applications.
While no company’s applications have been validated yet by the FSA, the target date to allow the recommended six weeks needed to gain validation of submitted Novel Food dossiers prior to 31 March is rapidly approaching.
With many UK brands searching urgently for assistance to secure Novel Food validation, as a market-leading manufacturer and brand-builder, BRITISH CANNABIS is well positioned to assist those brands that are struggling to stay on the market. This could give businesses peace-of-mind by providing another option to ensure their brands remain on the UK market.
From 1 April 2021, the FSA have indicated that various Trading Standards authorities will begin to remove CBD products from sale if a novel food dossier for that product is not received and validated before then.
Ensuring BRITISH CANNABIS™ Passes the Test
The manufacturing and quality control systems throughout the BRITISH CANNABIS supply chain ensure that finished products meet the requirements of the Novel Food regulations, from both a regulatory and commercial perspective.
A 90-day OECD 408 Toxicity Study undertaken by BRITISH CANNABIS, in conjunction with the ACI, on its primary ingredient will assess the effects that different delivery methods (ingestion, absorption, and inhalation) can have on the liver, and if there are any groups (children, adolescents, pregnant women) vulnerable to CBD’s effects.
The company is also undertaking a Cannabinoids Stability Programme on five independently produced batches of primary ingredient, in addition to testing its finished products. This programme is designed primarily to meet the “stability” assessment requirements of regulators.
As the BRITISH CANNABIS family of brands included in its application have been on the market for up to five years and their primary ingredients used in over one million product units, there is substantial usage data and evidence of safety as part of their dossier. This supports the product’s risk assessment and that they pose no risk to public health.
Providing enhanced protection from enforcement via manufacturing facilities based in England, BRITISH CANNABIS is not reliant on European supply for finished products. Upon achieving novel foods application validation, the company will thus see their complete onwards supply chain covered.
At this time, in both Scotland and the European Union, there exists a continued grey area with no set timelines for novel food action. This poses some brands a risk of enforcement for a further period of one or more years for applications to be fully authorised.
For brands made in England however, the starting line for successful brands comes as soon as 1 April 2021.
A Trading Standards partnership, formalised by the Home Office in January 2021, sees BRITISH CANNABIS, the ACI and Buckinghamshire and Surrey Trading Standards working in partnership to embed regulatory compliance into the rapidly developing CBD sector.
Being one of only a handful of UK companies included in the partnership will provide BRITISH CANNABIS and its white label clients further protection across the country.
CEO, Tom Whettem, commented on these developments: “We have considered every safety aspect when painstakingly preparing dossiers for these 200+ products. Our partnership with the ACI has been vital for this and the support we have received as part of our membership has been invaluable for both me and the leadership team in this family-owned business.”
He added: “Our products have now been on the market approaching six years, shipping hundreds of thousands of units and gaining thousands of fans and positive reviews in the process. It is a big motivator to me and my executive team that these customers can continue to have their lives made better by having reliable, effective, legal, cannabis-derived food supplements remain available as part of their diet.”
BRITISH CANNABIS has also seen a significant increase in its market share as the UK halts CBD imports from Europe following the implementation of Brexit; with many brands facing issues with border forces and interruptions to their supply chain.
With reports already that some products are being impounded and destroyed, it is a worrying time for many CBD brands.
Fortunately, this has not affected BRITISH CANNABIS and as a result some of the biggest and most loved brands have switched to this manufacturer in recent weeks.
These clients, new and existing, benefit from the rigorous in-house third-party product and batch testing that BRITISH CANNABIS has carried out for several years.
This ensures its products continue to meet the newly updated Home Office guidance on analytical limits for controlled cannabinoids.
Whettem concluded: “We are open to all suggestions from brand owners who want to see their products’ futures secured. Linking your brand to one of our dossiers does not obligate you to have your brand manufactured by us or to our formulas, but it may be a contingency plan you should think about having up your sleeve as we enter these crucial few weeks.”
BRITISH CANNABIS™ can be reached on +44 (0) 203 965 2420 or via email at firstname.lastname@example.org
CBD guides: Could CBD help with women’s intimate healthcare?
The endocannabinoid system can play a huge role in helping women’s health issues.
As the number of intimate care CBD products on the market continues to increase, we examine how CBD could help.
CBD has been associated with women’s health issues such as period pain relief, menopause insomnia and even hormonal acne. But as CBD is also thought to help us achieve homeostasis (balance) in the body, could it help to maintain vaginal health?
Women’s health and the endocannabinoid system
The endocannabinoid system is thought to regulate different functions in the body such as sleep, mood, appetite, memory and fertility. It is made up of receptors, enzymes and endocannabinoid that are found naturally all over the body. There are two major receptors called CB1 and CB2.
CB1 is usually found in the central nervous system, while CB2 is found in the peripheral nervous system. Endocannabinoids bind to the receptors to help with different problems such as pain.
The vagina, bladder and urinary tract also have endocannabinoid receptors.
CBD, unlike THC, does not bind the receptors. CBD may supplement the endocannabinoid system helping to regulate your system. The cannabinoids travel the receptor that has been stimulated and needs extra help to achieve a balance.
Depending on the dose and which receptor it is, CBD is thought to help anxiety, sleep problems, inflammation and pain.
This could be especially useful for those struggling with conditions such as endometriosis, painful periods or anxiety around sex.
When it comes to vaginal health and women’s health concerns in general, how could CBD help?
CBD may help with painful periods due to its anti-inflammatory properties. During a period, the uterus contracts to shed its lining while releasing hormone-like substances called prostaglandins. These substances are involved in inflammation and pain while triggering muscle contractions. Higher levels of prostaglandins may mean more painful menstrual cramps.
One study from 2019 revealed that women with endometriosis self-rated cannabis or CBD as most effective for soothing pain. This was compared with other practises such as yoga and stretching.
Another study, which was focused on arthritis in rats, found that CBD gel applied to the area may help to reduce pain and inflammation.
Endometriosis is an extremely painful condition that can be debilitating. The tissue from the uterus can become attach itself to other organs in the body such as fallopian tubes, ovaries or pelvis.
Studies have shown that women are increasingly turning to CBD for help alleviating the pain of endometriosis. There are on-going studies into how exactly CBD suppositories or tampons may help endometriosis but there are no results as of yet.
A study into fibromyalgia and pelvic pain for women from 2021 revealed that over one-third of the women surveyed were current CBD users with 81 per cent of this group stating the use had ‘improved their pain.’ A further 76 per cent of users said they were able to substitute CBD for other medications including opioids, NSAIDS, gabapentinoids and benzodiazapams.
There are many different reasons for vaginal dryness including menopause, medication and even particular times of a menstrual cycle.
CBD may help to soothe any redness or irritation caused by vaginal dryness. If the skin is more sensitive as a result the anti-inflammatory properties may reduce any swelling or issues of eczema or dermatitis.
CBD is thought to be potentially anti-fungal which may help with yeast infections.
However, its important to note, before you grab your CBD oil, that there are no direct studies for yeast infection. CBD may be able to boost the effects of caryophyllene oxide or beta-caryophyllene. Both of these are terpenes that are found in the cannabis plant. An older study from 1999 highlighted caryophyllene as a potential help for fungal infections in nails and the skin.
CBD may also offer some relief for irritated or itchy skin as a result of fungal infections such as candida. This is due to its potential anti-inflammatory properties which can help to reduce redness or swelling.
What is the best CBD to use internally?
While it may be tempting to use our existing CBD products in our intimate areas, it’s best not to.
CBD products for intimate areas are formulated to be used internally which means they are safe. Oils or topicals may contain ingredients or perfumes that can cause infections. The vagina contains a type of bacteria, a Lactobacillus. It produces lactic acid and helps to lower the pH of the vagina, but any form of imbalance can result in infections or thrush.
How to use CBD internally
The most common ways to use CBD vaginally are lubricants and suppositories.
While suppositories may seem scary, they can be one of the easiest ways to take CBD. They are made from from oils such as coconut, that can melt at body temperature. The CBD can take a few minutes to be absorbed by the body once it has melted the oil. It is worth noting that it can be a bit messy when the oil melts, so using something like a sanitary pad can place a barrier between your clothing and the oil.
Sex and women’s health
Latex and safety
Another way that oil-based products may cause a problem, is with latex. Oil can erode latex condoms or glide dams causing them to break or split. If CBD products are being used during sex, always make sure that the CBD being used is water-soluble.
Some people can feel really anxious around sex, due to past experiences, pain or being intimate with a new partner.
A lot of the studies conducted on anxiety and sexual anxiety appear to be focused on men. However, more general anxiety and CBD studies do have a more mixed-gender ratio.
A review from 2020 suggested that CBD could help with anxiety disorders. In reducing anxiety, a person’s libido may increase helping them to feel like sex more.
When the vagina is aroused, the mucous membranes in the vulva and vagina begin to produce a natural lubricant. This is also referred to as vasodilation, the natural process of our bodies expanding our blood vessels to allow more oxygen into certain tissues.
Some studies show that CBD may help with this process by increasing sensitivity and blood flow around the body. CBD is absorbed through the mucous membranes in the vagina and straight into the blood vessels. It is one of the quickest ways to absorb a dose of CBD as it doesn’t have to pass through the digestive system.
CBD suppositories and lubricants are designed to be used internally.
Does the endocannabinoid system have an effect on exercise euphoria?
What causes a runner’s high? Is it CBD, endorphins or our endocannabinoid systems?
The euphoric feeling after exercise, often referred to as a ‘runner’s high’, is associated with a reduction in pain, stress and anxiety.
Research now links the runner’s high to our endocannabinoid system, suggesting that the exercise-induced endorphin release it was always attributed to, is not solely responsible.
But what is our endocannabinoid system? And how does it work?
We examine endocannabinoids, endorphins and how CBD plays a part in balancing the body and exercise
What is the endocannabinoid system?
The endocannabinoid system is thought to regulate different functions in the body such as sleep, mood, appetite, memory and fertility. It is made up of receptors, enzymes and endocannabinoids.
Endocannabinoid receptors are found naturally all over the body. There are two major receptors called CB1 and CB2.
CB1 is usually found in the central nervous system, while CB2 is found in the peripheral nervous system. Endocannabinoids bind to the receptors to help with different problems such as pain. It is not fully understood how cannabinoids bind with receptors.
Endocannabinoids are actually naturally produced molecules that are similar to cannabinoids. So far, researchers have identified two key endocannabinoids: anandamide (AEA) and 2-arachidonoylglyerol (2-AG).
Enzymes break down the endocannabinoids once they are no longer needed. The two major enzymes are fatty acid amide hydrolase, which breaks down AEA and monoacylglycerol acid lipase, which typically breaks down 2-AG.
What is the difference between endocannabinoids and endorphins?
Endorphins are chemicals released by the body in response to pain or exercise. They were traditionally associated with the euphoria felt after a run. However, endorphins cannot cross into the brain through the blood-brain barrier which exists to protect the brain from toxins and pathogens.
How does CBD feature in all of this?
CBD interferes with the receptors found in the endocannabinoid system to help them balance the body. However, it is not fully understood how this happens.
CBD, unlike tetrahydrocannabinol (THC), another cannabinoid found in the plant, does not bind the receptors. CBD may supplement the endocannabinoid system helping to regulate your system. The cannabinoids travel the receptor that has been stimulated and needs extra help to achieve a balance. Depending on the dose and which receptor it is, CBD is thought to help anxiety, sleep problems, inflammation and pain.
This is why a lot of runners or athletes depend on CBD as part of their recovery routine after a strenuous workout. It may help to alleviate some of the muscle pain they endure during a run.
How this US brand is helping veterans access free CBD
“U.S. military veterans are some of the most selfless individuals so we thought the project would be a perfect fit.”
US vaping supply brand, CCELL, has partnered with the Veteran’s Walk and Talk project to provide free access to CBD.
CCELL will be partnering with the Veterans Walk and Talk (VWAT) to gift its members with limited edition CBD vapes that highlight their military service.
Veterans Walk and Talk is a community project based in the US, offering support, psychedelic therapy and cannabis.
It was founded in 2016 by Colin Wells, who served in the US Army, as a way for veterans in Southern California, Sacramento and Oklahoma, to take control of their health journey.
The project now holds regular community outreach events that provide veterans with a one-on-one psychedelic or cannabis walk and talk therapy or group hikes. They also hold trail and beach clean-ups where the community come together to give back to nature along with book clubs and comedy nights.
To mark the firm’s fifth anniversary, the CCELL team decided to join forces with VWAT.
Speaking with Cannabis Health, Joe Strain, vice president of CCELL said: “VWAT started with veterans in mind. Founder Colin Wells, who served in the US Army and experienced withdrawal traumas, began posting on social media to see if anybody wanted to join him on his hikes as a means to relieve stress.
“On these hikes, he’d provide free cannabis, education and a safe space for people to talk. These hikes inspired him to start VWAT as a way to give back to his community, with the main goal of reducing the suicide epidemic among veterans. Now, VWAT has 12 chapters across the country, all carrying the same mission.”
Joe added: “US military veterans are some of the most selfless individuals, so we thought they would be a perfect fit. We heard about what VWAT is doing for veterans and decided to support the organisation on its mission to help improve the lives and health of veterans by providing them with CBD vaporisers. The alignment was undeniable, and we’re honoured to be a part of helping them further their mission.”
Mental health and veterans
Mental health conditions such as anxiety, depression and post-traumatic stress disorder (PTSD) can be common among veterans. The symptoms of PTSD can be debilitating causing flashbacks, nightmares or physical effects such as nausea or pain.
A study from 2017 highlighted the difference in PTSD between veterans and civilians. In the study of 5,826 veterans, researchers recorded a rate of 13 per cent with PTSD. This is almost double the seven per cent of the US population with a PTSD diagnosis.
Studies show CBD may help PTSD by interacting with the endocannabinoid receptors in the body.
Joe explained: “It’s known that many veterans deal with PTSD after they have served. Studies have shown that CBD can be effective in reducing PTSD symptoms. This can potentially afford members the opportunity to manage their symptoms without excessive pharmaceutical drugs, which often cause side effects.”
He added: “CCELL has produced limited edition CBD vapes which will signify that the users of the vapes are members of Veteran’s Walk and Talk. Not only is this great for the members, but it is also significant for this non-profit organisation as it helps to spread awareness about the great work that VWAT does and will help encourage more people in need to join.”
Introducing our new B2B title
- Scottish MPs back medical cannabis patient following police action
- CBD guides: Could CBD help with women’s intimate healthcare?
- How CBG has been a game changer for my ADHD
- CBN discovery could lead to new treatments for Alzheimer’s, say researchers
- The Sisters of CBD giving away free hemp seeds in the US
- Boris Johnson faces fresh questions on NHS access to medical cannabis
News1 year ago
Community extends support to cannabis icon Rick Simpson
Case Studies2 years ago
CBD oil and fibromyalgia – a case study
News1 year ago
Cancer survivor claims cannabis oil helped her beat brain tumour
News2 years ago
NHS lines up cannabis medicine manufacturing
News1 year ago
UK grants second licence to grow high-THC medical cannabis
News1 year ago
Living with chronic fatigue – my CBD story
Insight1 year ago
I’ve gone from a wheelchair to walking thanks to cannabis
Feature2 years ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt